Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Accord healthcare

02 6Alembic Pharmaceuticals Limited

03 8Centocor

04 50Janssen-Cilag

05 46Johnson & Johnson Innovative Medicine

06 7Lannett Company, Inc.

07 8MSN Laboratories

08 8Pluviaendo

09 8RK Pharma

10 8STADA Arzneimittel

11 8Stada Laboratory Sl

12 8Zydus Lifesciences

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Bioprocess International Europe
Not Confirmed
arrow
arrow
Bioprocess International Europe
Not Confirmed

SELEXIPAG

Brand Name : UPTRAVI

Dosage Form : TABLET;ORAL

Dosage Strength : 0.2MG

Packaging :

Approval Date : 2015-12-21

Application Number : 207947

Regulatory Info : RX

Registration Country : USA

blank

02

Bioprocess International Europe
Not Confirmed
arrow
arrow
Bioprocess International Europe
Not Confirmed

SELEXIPAG

Brand Name : UPTRAVI

Dosage Form : TABLET;ORAL

Dosage Strength : 0.4MG

Packaging :

Approval Date : 2015-12-21

Application Number : 207947

Regulatory Info : RX

Registration Country : USA

blank

03

Bioprocess International Europe
Not Confirmed
arrow
arrow
Bioprocess International Europe
Not Confirmed

SELEXIPAG

Brand Name : UPTRAVI

Dosage Form : TABLET;ORAL

Dosage Strength : 0.6MG

Packaging :

Approval Date : 2015-12-21

Application Number : 207947

Regulatory Info : RX

Registration Country : USA

blank

04

Bioprocess International Europe
Not Confirmed
arrow
arrow
Bioprocess International Europe
Not Confirmed

SELEXIPAG

Brand Name : UPTRAVI

Dosage Form : TABLET;ORAL

Dosage Strength : 0.8MG

Packaging :

Approval Date : 2015-12-21

Application Number : 207947

Regulatory Info : RX

Registration Country : USA

blank

05

Bioprocess International Europe
Not Confirmed
arrow
arrow
Bioprocess International Europe
Not Confirmed

SELEXIPAG

Brand Name : UPTRAVI

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG

Packaging :

Approval Date : 2015-12-21

Application Number : 207947

Regulatory Info : RX

Registration Country : USA

blank

06

Bioprocess International Europe
Not Confirmed
arrow
arrow
Bioprocess International Europe
Not Confirmed

SELEXIPAG

Brand Name : UPTRAVI

Dosage Form : TABLET;ORAL

Dosage Strength : 1.2MG

Packaging :

Approval Date : 2015-12-21

Application Number : 207947

Regulatory Info : RX

Registration Country : USA

blank

07

Bioprocess International Europe
Not Confirmed
arrow
arrow
Bioprocess International Europe
Not Confirmed

SELEXIPAG

Brand Name : UPTRAVI

Dosage Form : TABLET;ORAL

Dosage Strength : 1.4MG

Packaging :

Approval Date : 2015-12-21

Application Number : 207947

Regulatory Info : RX

Registration Country : USA

blank

08

Bioprocess International Europe
Not Confirmed
arrow
arrow
Bioprocess International Europe
Not Confirmed

SELEXIPAG

Brand Name : UPTRAVI

Dosage Form : TABLET;ORAL

Dosage Strength : 1.6MG

Packaging :

Approval Date : 2015-12-21

Application Number : 207947

Regulatory Info : RX

Registration Country : USA

blank

09

Bioprocess International Europe
Not Confirmed
arrow
arrow
Bioprocess International Europe
Not Confirmed

SELEXIPAG

Brand Name : UPTRAVI

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : 1.8MG/VIAL

Packaging :

Approval Date : 2021-07-29

Application Number : 214275

Regulatory Info : RX

Registration Country : USA

blank

10

Bioprocess International Europe
Not Confirmed
arrow
arrow
Bioprocess International Europe
Not Confirmed

SELEXIPAG

Brand Name : SELEXIPAG

Dosage Form : TABLET;ORAL

Dosage Strength : 0.2MG

Packaging :

Approval Date :

Application Number : 214055

Regulatory Info :

Registration Country : USA

blank

11

Bioprocess International Europe
Not Confirmed
arrow
arrow
Bioprocess International Europe
Not Confirmed

SELEXIPAG

Brand Name : SELEXIPAG

Dosage Form : TABLET;ORAL

Dosage Strength : 0.4MG

Packaging :

Approval Date :

Application Number : 214055

Regulatory Info :

Registration Country : USA

blank

12

Bioprocess International Europe
Not Confirmed
arrow
arrow
Bioprocess International Europe
Not Confirmed

SELEXIPAG

Brand Name : SELEXIPAG

Dosage Form : TABLET;ORAL

Dosage Strength : 0.6MG

Packaging :

Approval Date :

Application Number : 214055

Regulatory Info :

Registration Country : USA

blank

13

Bioprocess International Europe
Not Confirmed
arrow
arrow
Bioprocess International Europe
Not Confirmed

SELEXIPAG

Brand Name : SELEXIPAG

Dosage Form : TABLET;ORAL

Dosage Strength : 0.8MG

Packaging :

Approval Date :

Application Number : 214055

Regulatory Info :

Registration Country : USA

blank

14

Bioprocess International Europe
Not Confirmed
arrow
arrow
Bioprocess International Europe
Not Confirmed

SELEXIPAG

Brand Name : SELEXIPAG

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG

Packaging :

Approval Date :

Application Number : 214055

Regulatory Info :

Registration Country : USA

blank

15

Bioprocess International Europe
Not Confirmed
arrow
arrow
Bioprocess International Europe
Not Confirmed

SELEXIPAG

Brand Name : SELEXIPAG

Dosage Form : TABLET;ORAL

Dosage Strength : 1.2MG

Packaging :

Approval Date :

Application Number : 214055

Regulatory Info :

Registration Country : USA

blank

16

Bioprocess International Europe
Not Confirmed
arrow
arrow
Bioprocess International Europe
Not Confirmed

SELEXIPAG

Brand Name : SELEXIPAG

Dosage Form : TABLET;ORAL

Dosage Strength : 1.4MG

Packaging :

Approval Date :

Application Number : 214055

Regulatory Info :

Registration Country : USA

blank

17

Bioprocess International Europe
Not Confirmed
arrow
arrow
Bioprocess International Europe
Not Confirmed

SELEXIPAG

Brand Name : SELEXIPAG

Dosage Form : TABLET;ORAL

Dosage Strength : 1.6MG

Packaging :

Approval Date :

Application Number : 214055

Regulatory Info :

Registration Country : USA

blank

18

Bioprocess International Europe
Not Confirmed
arrow
arrow
Bioprocess International Europe
Not Confirmed

SELEXIPAG

Brand Name : SELEXIPAG

Dosage Form : TABLET;ORAL

Dosage Strength : 0.2MG

Packaging :

Approval Date : 2022-12-21

Application Number : 214302

Regulatory Info : DISCN

Registration Country : USA

blank

19

Bioprocess International Europe
Not Confirmed
arrow
arrow
Bioprocess International Europe
Not Confirmed

SELEXIPAG

Brand Name : SELEXIPAG

Dosage Form : TABLET;ORAL

Dosage Strength : 0.4MG

Packaging :

Approval Date : 2022-12-21

Application Number : 214302

Regulatory Info : DISCN

Registration Country : USA

blank

20

Bioprocess International Europe
Not Confirmed
arrow
arrow
Bioprocess International Europe
Not Confirmed

SELEXIPAG

Brand Name : SELEXIPAG

Dosage Form : TABLET;ORAL

Dosage Strength : 0.6MG

Packaging :

Approval Date : 2022-12-21

Application Number : 214302

Regulatory Info : DISCN

Registration Country : USA

blank